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One sentence summary: Kidney response to infection is influenced by both host and pathogen. The structure of bacterial LPS effects the kinetics of






Bacterial infection of the kidney leads to a rapid cascade of host protective responses, many of which are still poorly
understood. We have previously shown that following kidney infection with uropathogenic Escherichia coli (UPEC), vascular
coagulation is quickly initiated in local perivascular capillaries that protects the host from progressing from a local infection
to systemic sepsis. The signaling mechanisms behind this response have not however been described. In this study, we use
a number of in vitro and in vivo techniques, including intravital microscopy, to identify two previously unrecognized
components influencing this protective coagulation response. The acylation state of the Lipid A of UPEC lipopolysaccharide
(LPS) is shown to alter the kinetics of local coagulation onset in vivo. We also identify epithelial CD147 as a potential host
factor influencing infection-mediated coagulation. CD147 is expressed by renal proximal epithelial cells infected with UPEC,
contingent to bacterial expression of the α-hemolysin toxin. The epithelial CD147 subsequently can activate tissue factor on
endothelial cells, a primary step in the coagulation cascade. This study emphasizes the rapid, multifaceted response of the
kidney tissue to bacterial infection and the interplay between host and pathogen during the early hours of renal infection.
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INTRODUCTION
Bacterial infection of the kidney leads to an immediate and
complex ‘dialogue’ between host and pathogen that is influ-
enced by the bacterial repertoire of virulence factors, the host
immune response and the microenvironment of the tissue.
Understanding the sometimes-subtle interplay between these
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Table 1. Bacterial strains, plasmids and oligonucleotides.
Strain Genotype Reference
CFT073 O6:K2:H1 (Mobley et al. 1990; Mansson et al. 2007)
LT002 CFT073 hlyA::kmr (Mansson et al. 2007)
LT004 CFT073 cobS::  (PLtetO-1-gfp+), cmr (Mansson et al. 2007)
LT005 LT004 hlyA::kmr (Mansson et al. 2007)
LT004  msbB LT004 msbB::kmr This study
Plasmids
pKD4 Kanamycin resistance cassette source (Datsenko and Wanner 2000)








factors is crucial to understanding the complete picture of
kidney infection in vivo. We previously developed a ‘Tissue Mi-
crobiology’ in vivo model of uropathogenic Escherichia coli (UPEC)
infection to study this interaction (Mansson et al. 2007; Meli-
can et al. 2008; Melican et al. 2011). Combining the spatial and
temporal control of microinfusion with multiphoton intravital
microscopy, this model allowed us to study UPEC infection in
‘real-time’ within living kidneys. Visualizing the ongoing infec-
tion process, with subcellular resolution, revealed a remarkable
complexity. Differential expression of bacterial virulence factors
was shown to alter the course of infection in terms of bacte-
rial adhesion and bacterial lifestyles (Mansson et al. 2007; Mel-
ican et al. 2008; Melican et al. 2011). We also demonstrated the
effect of these bacterial virulence factors in influencing the ki-
netics of the host inflammatory response (Mansson et al. 2007;
Melican et al. 2008; Melican et al. 2011). A major finding from
this previous work was that UPEC infection of kidney tubules
induces a rapid vascular coagulation in local peritubular capil-
laries (Melican et al. 2008). This coagulation leads to local tis-
sue hypoxia and vascular isolation of the infection site, prevent-
ing a progression to sepsis and facilitating bacterial clearance
(Melican et al. 2008).
The next step has been to find the signaling mechanisms
that initiate this infection-mediated vascular coagulation. A
key point is that at the onset of this coagulation, bacteria are
still located at the epithelial barrier and not in direct contact
with the blood vessels. The importance of understanding the
complex associations between bacterial infection and coagula-
tion has been highlighted in recent reviews (Davis, Miller-Dorey
and Jenne 2016; Peetermans et al. 2016). Coagulation in re-
sponse to bacterial sepsis and blood-borne bacteria has been
comprehensively studied (McDonald et al. 2017). Sepsis can be
considered, however, a ‘late stage’ of infection, the result of a
local infection that the host has failed to control. Our previous
work showed that if coagulation can be initiated before bacteria
came into direct contact with the blood vessels, sepsis might be
avoidable (Melican et al. 2008). This indicates that there is some
form of cell-cell communication from the infected epithelia,
initiating the protective coagulation response, prior to the onset
of sepsis. An important aspect of clinical treatment of sepsis is
the use of anticoagulants. We have shown that anticoagulation
may actually enhance the progression from local to systemic
infection by disrupting this important protective response
(Melican et al. 2008). It is becoming more apparent through both
basic research and clinical trials that there is a need to be able to
functionally uncouple essential physiological hemostasis and
infection-mediated coagulation so that we can pharmacologi-
cally target only the latter when necessary (Davis, Miller-Dorey
and Jenne 2016). It may also be that by understanding the
mechanism of this protective response that we may be able to
harness or enhance this as an immunotherapeutic alternative
to antibiotic treatment of early stage infections.
Deciphering the mechanisms initiating infection-mediated
coagulation during the early hours of bacterial infection is the
focus of this work. Our hypothesis is that signaling events occur-
ring at the bacterial-epithelial interface initiates tissue signaling
which leads to a coagulation response in the local vasculature.
To address this, we analyze both host and bacterial elements of




Bacterial strains, plasmids and oligonucleotides are presented
in Table 1. LT004 msbB, was created using the one step allelic
knockoutmethod (Datsenko andWanner 2000), a kanamycin re-
sistance cassette was inserted into the msbB gene of LT004 be-
tween nt 281,464–281,858. No significant alterations in growth
rates, capsule morphology or expression of α-hemolysin were
observed. Bacteria were grown in Luria broth aerated over night
at 37◦C. On the day of infection, bacteria were diluted 1:50 or
1:100 and grown to OD600nm 0.5, corresponding to ≈108 CFU/ml.
Human cells
RPTEC/TERT1 (ATCC R© CRL-4031) cells were plated at 2 × 106
cells per well and grown for 11 days at 37◦C, 5% CO2, 95% humid-
ity in complete DMEM-F12 media containing DMEM-F12 (ATCC,
Sweden cat #30–2006), 5pM T3 (#T6397), 10 ng/ml recombinant
human EGF (#PMG8041, Life Technologies), 3.5 μg/ml ascorbic
acid (#A4403), 5 μg/ml human transferrin (#T1147), 5 μg/ml
bovine insulin (#I6634), 25 ng/ml prostaglandin E1 (#P8908),
25 ng/ml hydrocortisone (#H0888), 8.65 ng/ml sodium selenite
(#S5261) and 100μg/ml G418 (#G418-RO) (Sigma, Sweden). Mono-
layer formation, was evaluated using a mouse-anti human-ZO1
antibody (Invitrogen, Sweden cat #339 100), Cy3- donkey anti-
mouse IgG (Jackson Immunoresearch Europe cat#715–1650-150)
Phalloidin-Alexa Fluor633 (Life Technologies, Sweden, cat
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#A22284) and Hoechst 33 258 pentahydrate (bis-benzimide)
(Life Technologies, Sweden cat # H1398). LIVE/DEAD R© Viabil-
ity/Cytotoxicity kit (Invitrogen, Sweden cat #L3224) for eukary-
otic cells was used according to themanufacturer’s instructions.
HMEC-1 ATCC R© CRL-3243
TM
was grown in MCDB 131medium
(#10 372 019, Invitrogen, Sweden) supplemented with 10%
of FBS (Lot # 111M3397 Sigma, Sweden), 10 mM GlutaMAX
(#35 050 061, Gibco), 10 ng/ml recombinant mouse epidermal
growth factor (mEGF # PMG804, Life Technologies) and 1 μg/ml
of hydrocortisone (# H0888 Sigma) at 37◦C and 5% CO2.
Epithelial cell infection
Cells were infected at an MOI of 1:20 or stimulated with 5μg/ml
lipopolysaccharide (LPS). LPS was either prepared as previously
described (Backhed et al. 2001) or Ultrapure K-12 LPS (Invito-
gen, France, cat #tlrl-peklps). Where indicated, bacteria or me-
dia were pre-treated with Polymyxin B (PMB) (Sigma–Aldrich cat
#P4932), 8U/ml, for 30 min at 8◦C.
Endothelial cell stimulation
HMEC-1 cells were plated at 8 × 105 cells per well. Cells were
stimulated for 4 h at 37◦C with aliquots of supernatant collected
from the ‘Epithelial cell infection’ described above, (diluted 1:5),
LPS (5μg/ml) or PMB (8 U/ml) in complete RPTEC/TERT1 medium
(see above). The complete DMEM-F12 medium did not activate
HMEC-1 cytokine/chemokine secretion. Cell supernatants were
collected, centrifuged and stored at −80◦C.
Cytokine and chemokine determinations
ELISA kits for IL-6 (#550 799), IL-8 (#555 244 BD Bioscience),
EMMPRIN (#DY972) and DPPVI/CD26 (#DY1180 R&D Systems,
Minneapolis, MN) were used according to themanufacturer’s in-
structions. IL-6 (# 558 276), IL-8 (# 558 277), IL-1β (# 558 279) and
TNF-α (# 560 112) were analyzed simultaneously using the Cy-
tometric Bead Array (CBA) Human Master Buffer Kit (#558 264
BD Biosciences, Sweden), using a FACS Canto II flow cytometer
operated with the FACSDiva software. Data were analyzed with
FCAP Array software, following the manufacturer’s tutorial.
Tissue factor determination
Cell lysates were prepared by lysis using 150 μl 15mM octyl-ß-
D-glycopyranoside (#O8001 Sigma, Sweden) for 15 min at 37◦C
or by 3 repeated cycles of freeze-thaws in 150 μl of buffer of 50
mM Tris-HCl, 100 mM NaCl, 0.1% Triton X-100, pH 7.4. Tissue
factor (TF) was extracted for 18 h at 4◦C –8◦C. TF-procoagulant
activity was measured using either the chromogenic assay
ACTICHROME R© TF kit (Sekisui Diagnostics, # 846) or TF Human
Chromogenic Activity Assay Kit (ABCAM, #ab108906) according
to the manufacturer’s instructions.
Animals
Studies were performed in accordance with the National Insti-
tutes of Health’s Guide for the Care and Use of Laboratory Animals
and were approved by the Institutional Animal Care and Use
Committee (Indianapolis, Indiana, USA). Male Munich–Wistar
rats (255 ± 22 g body weight) (Harlan, USA), with free access to
chowandwater, were used. Ratswere anesthetizedwith 130–150
mg/kg thiobutabarbital (Inactin) (#T133 Sigma, St. Louis, MO and
Sigma, Sweden). Animals underwent tracheostomy, cannulation
of a femoral artery, femoral vein and jugular vein. Infection by
tubular microperfusion was performed as previously described
(Mansson et al. 2007). Fresh LT004msbBwas cultivated and con-
centrated to 109 CFU/ml in PBS+ (PBS with 1mMCaCl2 and 2mM
MgCl2) containing 1 mg/ml Fast Green FCF (Fisher, Fair Lawn, NJ)
and 0.2 mg/ml cascade blue-conjugated 10 kDa dextran (#D1976
Molecular Probes, Eugene, OR). The left kidney was exposed via
a subcostal flank incision and supported in a kidney cup. The
bacterial suspension was infused over 10 min into the lumen
of superficial proximal tubules using a micromanipulator (Leitz
or World Precision Instruments, UK) and mercury leveling bulb.
Bacteria or PBS were infused at an average rate of 54 nl/min.
Multiphoton microscopy
All multiphoton imaging was performed using the set-up pre-
viously optimized and described (Mansson et al. 2007; Melican
et al. 2008). Images were collected using a Bio-Rad MRC 1024
confocal/2-photon system (Bio-Rad, Hercules, CA) attached to a
Nikon Diaphot inverted microscope (Fryer Co, Huntley, IL) with
a Nikon 20x water-immersion objective. Images were collected
using an excitation wavelength of 810 nm and neutral density
filters set to 25%–40%. Fluorescent probes were injected as a sin-
gle bolus via a jugular vein access line. Tetramethylrhodamine-
conjugated 500 kDa dextran (∼2.5 mg/400 μl 0.9% saline, Molec-
ular Probes, Eugene, OR) and Hoechst 33 342 (∼600 μg/0.4 ml
of 0.9% saline, Molecular Probes, Eugene, OR). Line scan mea-
surements were performed as previously described (Kleinfeld
et al. 1998), and as illustrated in Fig. 3. For line scanning, a cap-
illary adjacent to the infected tubule, which lay parallel to scan
head direction, was required. Typically, only the single most ap-
propriate capillary per infection site (n = 4) was selected for
scanning. Images and data-volumeswere processed usingMeta-
morph Image Processing Software (Universal Imaging-Molecular
Devices, PA, USA), and Image J (U. S. National Institutes of Health,
MD, http://rsb.info.nih.gov/ij/). Final figures were prepared with
Adobe Photoshop (Adobe, CA, USA).
Proteome Array
The human XL Cytokine array kit (Proteome ProfilerTM array)
(R&D Systems, # ARY022B) was used according to manufac-
turer’s protocols. The chemiluminescencewasmeasured using a
imageQuant LAS 4000 (GE Healthcare Bio-Sciences AB, Uppsala,
Sweden). Spot size and pixel intensity were determined using
ImageJ software Fiji (NIH, Bethesda, MD, USA).
EMMPRIN and CD26 stimulation
Endothelial cells were stimulated with homo-dimer human
recombinant EMMPRIN (Abcam, Sweden #AB155636) or hu-
man CD26/DPP4 recombinant protein (Sino Biological #10 688-
HNCH-10) for 4 h before TF activation determination at the noted
concentrations.
Statistical analysis
Data are shown as mean ± standard deviation (SD). Statistics
were determined using ANOVA with Tukeys correction for mul-
tiple comparisons. Independent samples were analyzed using
an unpaired t-test with Welches correction. The proteome array
was analyzed with an uncorrected multiple t-test. Significance
is considered = P ≤ 0.05 and annotated by ∗ unless otherwise
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Figure 1. Epithelial cell response to UPEC infection. (A) Schematic of the in vitro infection model system. (B) Z0–1 staining (green) showing tight junction formation in
RPTEC/TERT1 cells at cultivation day 10. Cell nuclei are seen in blue. (C) ELISA measurements of basal IL-8 and (D) IL-6 expression in RPTEC/TERT1 cells on days 1 to 6
of cultivation, n = 3. (E) IL-8 and (F) IL-6 expression in renal RPTEC/TERT1 epithelial cells infected with an MOI 1:20 of CFT073 (dark grey) or LT002 (light grey) for 2, 4
and 6 h. Uninfected cell culture medium (black) was used as the comparative control. Expression was measured using the cytometric bead array (CBA), n = 5. All bars
represent mean ± SD. Significance was tested with a 2-way ANOVA with Turkeys post-test for multiple comparisons.
stated. All data were analyzed using the GraphPad inStat ver-
sion 6.0 (GraphPad software, San Diego, CA, USA).
RESULTS
Epithelial cell inflammatory responses to UPEC
infection
To study the communication between infected renal proximal
tubule epithelial cells and vascular endothelial cells we used a
controlled 2-step in vitro cell culture model (Fig. 1A). In an ef-
fort to faithfully replicate the in vivo microenvironment of the
kidney, we sought an epithelial cell line that closely replicated
the morphological and functional characteristics of renal prox-
imal tubules. We used RPTEC/TERT1 (ATCC R© CRL-4031), a hu-
man renal epithelial cell line that has been shown to reproduce
renal proximal tubular characteristics in both 2D and 3D culture
(Wieser et al. 2008; Simon-Friedt et al. 2015; Secker et al. 2018).
We optimized growth conditions, with extended (10 day) cultur-
ing, high-density seeding and frequent media changes, which
resulted in a confluent monolayer that displayed tight junction
formation (Fig. 1B), dome formation indicative of fluid transport
and a reduced basal cytokine secretion over time (Fig. 1C, D).
Tubular infection was modeled by infecting RPTEC/TERT1 with
the prototypic UPEC strain CFT073 (Table 1) at an MOI of 1:20.
As the response of RPTEC/TERT1 to bacterial infection had not
been previously reported, we started by evaluating the epithe-
lial inflammatory profile of these cells following UPEC infection.
Supernatants from infected RPTEC/TERT1 were collected at 2, 4
and 6 h post infection and the epithelial inflammatory profile
evaluated using a cytometric bead array (CBA). CFT073 infection
led to no increase in epithelial IL-8 or IL-6 (Fig. 1E, F). We have
shown previously that expression of the UPEC protein toxin α-
hemolysin affects the kinetics of infection-mediated coagula-
tion in vivo (Mansson et al. 2007). To analyze the epithelial in-
flammatory response in the absence of α-hemolysin,we infected
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RPTEC/TERT1 with LT002, an isogenic mutant of CFT073 that
lacks expression of the α-hemolysin toxin (hly) (Table 1). Fol-
lowing LT002 infection, epithelial IL-8 (Fig. 1E) and IL-6 (Fig. 1E)
production was increased at 4 and 6 h. The α-hemolysin toxin
expressed by UPEC has a concentration-dependent bi-phasic ac-
tion either modulating cell signaling at sub-lytic concentrations
or as a cytotoxic pore-forming toxin at higher concentrations
(Uhlen et al. 2000; Dhakal andMulvey 2012).We evaluated the cy-
totoxic action of α-hemolysin on RPTEC/TERT1 using a live dead
assay (Supplementary Fig. S1), which showed that infectionwith
the α-hemolysin expressing CFT073 strain caused increased ep-
ithelial cell death/detachment after 6 h of infection when com-
pared to the LT002 (hly) strain.
Together this data indicated that the RPTEC/TERT1 cell line
could respond to UPEC infection, and that bacterial expression
of the toxin HlyA influenced the renal epithelial inflammatory
response, a phenomenon that has been previously described on
bladder epithelial cells (Dhakal and Mulvey 2012; Hilbert et al.
2012; Ristow and Welch 2016).
Endothelial cell activation following epithelial cell
infection
We then investigated how endothelial cells may respond to the
multitude of factors produced by infected renal epithelia. Work-
ing fromour previous in vivo data showing initiation of infection-
mediated coagulation at 4 h (Melican et al. 2008), we focused on
signaling components produced up to 4 h post infection. Super-
natant from a 4 h epithelial infection (step 1, Fig. 1A) was col-
lected, filtered (0.2um) and then used to stimulate a human mi-
crovascular endothelial cell line (HMEC-1) for 4 h (Step 2, Fig. 1A).
HMEC-1 cells stimulated for 4 h with supernatant from
CFT073 infected epithelial cells showed an increased production
of IL-8, IL-6 and IL-1β, and amoderate increase of TNF-α (Fig. 2A-
D). Endothelial stimulation with supernatant from LT002 (hly)
infected epithelial cells showed a similar pattern, with signifi-
cant up-regulation of IL-8, IL-6, and an increase of TNF-α and
IL-1β (Fig. 2A-D). The similarity of the endothelial response to
the supernatants from the different epithelial infections (Fig. 1E)
demonstrated that epithelial production of IL-8 and IL-6 are not
decisive factors in this cell-cell signaling and that other factors
must be involved.
We were also interested in the ability of the epithelial factors
to induce coagulation. Tissue factor (TF) is a central regulator of
the coagulation cascade. We therefore measured the activation
of endothelial TF following stimulation with infected epithelial
supernatants. Stimulation of endothelial cells with supernatant
from epithelial cells infected with both CFT073 and LT002 led
to significant endothelial TF activation (Fig. 2E). This data sup-
ports our hypothesis that factors originating from the infected
epithelium canmediate endothelial activation and the initiation
of coagulation.
Role of LPS Lipid A in endothelial activation
We then investigated what factors may be mediating TF acti-
vation. A major component of the filtered supernatants is the
bacterial endotoxin LPS. As bacteria grow, they shed significant
amounts of LPS into their environment (Mattsby-Baltzer et al.
1991). Control experiments with purified LPS showed that LPS
alone could stimulate endothelial production of IL-8, IL-6 and
IL-1β (Supplementary Fig. 2A-D) and also induced significant TF
activation (Supplementary Fig. 2E).
To study the extent of the role played by LPS in endothelial ac-
tivation in our model, we used the antibiotic Polymyxin B (PMB),
which binds to the lipid A portion of LPS, antagonizing LPS- TLR4
signaling (Backhed et al. 2003). Control experiments confirmed
that PMB treatment (8 U/ml) of purified LPS reduced endothe-
lial IL-8, IL-6 and IL-1β production as well as TF activation (Sup-
plementary Fig. 2A-E). PMB treatment of the supernatant from
epithelial cells infected with both CFT073 and LT002 prior to en-
dothelial cell stimulation (Step 2, Fig. 1A), resulted in a reduc-
tion in endothelial IL-8 and IL-6 production (Fig. 2A,B,+PMB). En-
dothelial TF activation was significantly reduced following PMB
treatment of the supernatant from CFT073 and LT002 infected
epithelial cells (Fig. 2E, +PMB).
The reduction in both cytokine signaling (Fig. 2A-D) and TF
activation (Fig. 2E) was, however, not complete abrogation. PMB
treated supernatant fromboth CFT073 and LT002 still stimulated
a significant IL-8 and IL-6 response when compared to its non-
infected controls (Fig. 2A-B,+PMB). PMB treated epithelial super-
natants also showed an increase in TF activation (Fig. 2E, +PMB).
These results indicate that lipid A mediated LPS signaling is an
important element in our in vitromodel, and blocking it reduces,
but does not eliminate, inflammation and TF activation.
LPS lipid A mediated signaling affects coagulation
kinetics in vivo
Testing the relevance of this lipid A mediated LPS signaling in
vivo is more challenging. PMB is nephrotoxic and cannot be used
in animal studies (Falagas and Kasiakou 2006). To overcome this,
we used an isogenic msbB mutant of the GFP expressing CFT073
strain LT004, LT004 msbB (Table 1), which produces a penta-
acylated lipid A that is poorly recognized by the TLR4 signalling
complex (Somerville et al. 1996; Backhed et al. 2003). Epithelial
infection in vitro with LT004 msbB for 4 h showed lower IL-
8 (Fig. 2F) and TF activation (Fig. 2G) in stimulated endothe-
lial cells, as compared to its CFT073 counterpart (Fig. 2A, 2E).
In agreement with the PMB results, neither of these reductions
were complete abrogation (Fig. 2F, G), with LT004 msbB epithe-
lial infection still demonstrating a significant effect on endothe-
lial TF activation. This confirmed the reduced inflammatory pro-
file of LT004msbB and a reduced, though not eliminated, ability
of this strain to induce TF activation in vitro.
To test the role of lipid A in infection-mediated coagulation in
vivo LT004 msbBwas introduced into our renal infection model
(Melican et al. 2008). LT004 msbB was microinfused (105 CFU in
40μl over 10 min) into a single proximal tubule of an exposed
kidney in a live rat and the progress of infection followed by in-
travital multiphotonmicroscopy. The LT004 msbB strain (green
in Fig. 3A) adhered to and colonized the renal epithelium (Fig. 3A,
2 h – 8 h). Within 4–5 h, the bacteria filled the tubular lumen in
themajority of infected tubules (Fig. 3A, 4–5.5 h). Bacterial adher-
ence and colonization patterns were comparable to that previ-
ously described for the LT004 (Mansson et al. 2007; Melican et al.
2008). The first signs of vascular perturbation and coagulation
(assessed by the red plasma marker in Fig. 3A) were seen ap-
proximately 6.5 h after infection (Fig. 3A, 6.5 h arrow). This rep-
resented a delay compared to the 4–5 h time frame seen in LT004
infection (Mansson et al. 2007; Melican et al. 2008). To measure
the velocity of red blood cells (RBC) in the peritubular capillar-
ies, line scanning (Kleinfeld et al. 1998) was performed (Fig. 3B-
D). A peritubular capillary adjacent to the infected tubule was
scanned along its central axis at 2ms per line for 4 s (Fig. 3B dot-
ted line). Individual RBC velocity was determined by calculating
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Figure 2. Activation of endothelial cells by supernatant from infected epithelia. (A) IL-8, (B) IL-6, (C) TNF-α and (D) IL-1β expression measured by CBA from HMEC-1
endothelial cells stimulated for 4 h with supernatant from RPTEC/TERT1 epithelial cells infected for 4 h with either CFT073 or LT002 n = 5. Supernatant from epithelial
cultures treated with uninfected cell culturemediumwas used as a comparative control. Epithelial supernatants were pre-treated with 8 U/ml PMB prior to endothelial
stimulation (+PMB), n = 5. (E) TF pro-coagulant activity, pM,measured using chromogenic assays, in HMEC-1 cells treated with supernatant from infected RPTEC/TERT1
epithelial cells as described above, n = 5 (F) IL-8 expression measured by ELISA of HMEC-1 cells stimulated for 4 h with supernatant from RPTEC/TERT1 epithelial cells
infected with LT004 msbB for 4 h, n = 3 (G) TF pro-coagulant activity, pM, in HMEC-1 cells treated for 4 h with supernatant from RPTEC/TERT1 infected with LT004
msbB for 4 h, n = 5. All bars represent mean ± SD. In A-E statistical significance (P = < 0.05) is shown by the use of symbols corresponding to the comparative
experiment. i.e. significance to the medium control is shown with ∗ and significance to the CFT073 culture is shown by #.
the distance it travelled through the vessel over time (Fig. 3C).
Line scanning demonstrated a gradual slowing in RBC flow fol-
lowing LT004 msbB infection (Fig. 3D). In wild-type LT004 infec-
tions the RBC rate has been shown to drop to 0 μm/sec by 4.5 h
(Melican et al. 2008). This data confirmed a slowing of infection-
mediated coagulation kinetics in response to the penta-acylated
lipid A of LT004 msbB, but not complete abrogation of coagu-
lation. This demonstrates a role for lipid A mediated signaling
in modulating the kinetics of infection-mediated coagulation in
vivo.
Host epithelial signaling factors induce endothelial
tissue factor activation.
The acylation state of lipid A can now join α-hemolysin as bac-
terial factors affecting the kinetics of infection-mediated coag-
ulation in vivo, however, neither of these bacterial factors act in
isolation (Amori, Lau and Pittas 2007; Melican et al. 2008). Elimi-
nation of either of these factors is not enough to completely ab-
rogate infection-mediated coagulation, but rather delay its on-
set. Our data also indicated that other factorsmay be involved in
this response as the msbB mutation could not completely elimi-
nate the TF activation response (Fig. 2G). Our hypothesis is that
in vivo the expression of these bacterial virulence factors affects
the epithelial response to infection rather than acting directly
on the endothelium as occurs in the in vitro models.
We therefore screened for candidate host derived molecules
involved in infection- mediated coagulation by performing a
proteome array study on supernatant from RPTEC/TERT1 cells
infected with the wild-type CFT073 strain. The array covered 106
human cytokines (see methods). Following 4 h of epithelial in-
fection we could detect signal for 15 proteins (Fig. 4A). Of these,
ICAM-1, CD26 and CD147 were significantly up-regulated com-
pared to non-infected controls. ICAM-1 up-regulation in UPEC
infection has already been reported, and is believed to be in-
volved in neutrophil recruitment (Mansson et al. 2007). CD26
(also known as DPPIV) and CD147 (also known as EMMPRIN) rep-
resent new candidate proteins in epithelial UPEC infection.
To confirm the infection-induced production of CD26 and
CD147 we performed ELISA on supernatant of RPTEC/TERT1
cells infected with CFT073 for 4 h. Infection induced signifi-
cant levels of both CD26 and CD147 in epithelial supernatant
(Fig. 4B,C). As we had seen that LPS played a role in infection
kinetics, we tested whether LPS alone could stimulate CD26
and CD147. Stimulation of epithelial cells with purified LPS
(5mg/ml) for 4 h did not induce release of either CD26 or CD147
into the supernatant (Fig. 4B, C), demonstrating a limited role
for the Lipid A pathway in this response. To evaluate the role
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Figure 3. Penta-acylated Lipid A delays coagulation in vivo. Representative intravital microscopy showing the infection kinetics over time of (A) LT004 msbB microin-
fused into a single renal proximal tubule of a live rat (n = 4). Bacteria express GFP (green), blood plasma is visualized by i.v. delivered 500 kDa tetramethylrhodamine
conjugated dextran (red) and cell nuclei with i.v. delivered Hoechst 33 342 (cyan). The infected tubule is outlined with a 10 kDa cascade blue conjugated dextran
co-infused with the bacteria and selectively endocytosed by the proximal tubule cells (blue). Scale bars = 30 μm. (B) Reference image showing the location of the line
scan (dashed line). The arrow shows the location of the vessel of interest shown in (C). (C) Part of the cross-section of the line scan from (B) showing the calculation of
RBC velocity, calculated by determining the distance d a RBC has travelled over time t. (D) Representative RBC velocity in the selected vessel adjacent to an LT004
msbB infected tubule (vessel shown in B) over time.
of α-hemolysin in this signaling, we tested supernatant from
epithelial cells infected with the α-hemolysin deficient LT002
strain. No CD26 or CD147 was released from epithelial cells
infected with LT002 (Fig. 4B, C). This suggests that their release
appears to be specific to infection with the wild-type CFT073
bacteria, the strain that shows the most rapid coagulatory
response in vivo (Mansson et al. 2007).
To investigatewhether CD26 andCD147mayplay a direct role
in infection-mediated coagulation caused by CFT073, we stimu-
lated HMEC-1 endothelial cells with purified CD26 and CD147
and tested for TF activation. Concentrations of active human
CD26 from 10–50 ng/ml showed no significant up-regulation of
endothelial TF activation following 4 h of stimulation (Fig. 4E).
CD147, however, revealed an increase in endothelial TF ac-
tivation at 4 h at higher concentrations (50mg/ml) (Fig. 4E).
This data implies that high local concentrations of CD147,
expressed by CFT073 infected epithelia, could play a role in
epithelial-endothelial signaling and the initiation of infection-
mediated coagulation during renal infection. This suggests
CD147 as a possible host-derived factor in infection-mediated
coagulation.
DISCUSSION
This work highlights two new players in host-pathogen cross-
talk that influences local infection-mediated coagulation: (1) the
acylation state of bacterial LPS and (2) host derived CD147. The
importance of infection-mediated coagulation has already been
shown; it plays a protective role in renal UPEC infection, prevent-
ing the transition to urosepsis (Melican et al. 2008). Our present
work adds new knowledge by showing that both bacterial viru-
lence determinants and host cell factors are involved in the ac-
tivation of TF.
The role of Lipid A and effect of the msbB mutation on
TLR4 mediated IL-8 production has been reported previously
(Backhed et al. 2001) but the exclusivity of this interaction in
UPEC urinary tract infection has been less clear (Hedlund et al.
1999; Backhed et al. 2003). Ambiguity in previous results using
the common renal epithelial cell line A498 (Backhed et al. 2001;
Demirel et al. 2015), led us to seek out an alternative in vitro
model that more closely represented the morphology of the in
vivo microenvironment. The RPTEC/TERT1 cell line originates
from a healthy male donor and is immortalized by telomerase
overexpression (Wieser et al. 2008). This line is being exten-
sively used as a model for nephrotoxicity (Simon-Friedt et al.
2015). Our data demonstrated that this cell line did respond to
UPEC infection. The lack of IL-6 and IL-8 signaling in response
to the hemolysin expressing CFT073 strain suggests that
hemolysin may influence the regulation of pro-inflammatory
signaling, as has been well described in bladder epithelium
(Dhakal and Mulvey 2012; Hilbert et al. 2012) and even for
the non-related Staphylococcus aureus beta-hemolysin toxin
(Tajima et al. 2009).
Antagonizing Lipid A mediated signaling in vitro with
polymyxin B demonstrated a significant role for this pathway
in the activation of the endothelial cell line. A drawback of our
in vitro model is that the bacterial products come into direct
contact with the endothelia, a situation we do not believe
represents the in vivo situation. We see coagulation occurring
in vivo when bacteria and seemingly their products are still
maintained at the epithelial barrier (Melican et al. 2008; Melican
et al. 2011). In vivo infection with the penta-acylated lipid A
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Figure 4. Epithelial signaling factors induce endothelial TF activation. (A) Proteome array of supernatant of epithelial cells infected with CFT073 for 4 h. Supernatant
from uninfected cells was used as the comparative control. Bars represent index of mean pixel density from the nitrocellulose membranes, n = 3. (B) CD26 and (C)
CD147 expression in the supernatant of RPTEC/TERT1 cells stimulated for 4 h with cell culture medium, 5 mg/ml LPS or infected at an MOI 1:20 with CFT073 or LT002.
Measurements were performed by ELISA, n = 5. (D) TF pro-coagulant activity, pM, measured using chromogenic assays in endothelial cells treated with the noted
concentrations of (D) CD26, or (E) CD147, n = 3. All bars represent mean ± SD.
UPEC strain demonstrated slower kinetics, though not elimi-
nation, of coagulation as compared with the WT strain. While
a strain may have a less immunogenic LPS, it can still express
α-hemolysin, and, as each of these factors appears to play a
role in the onset of coagulation, the result is a nuanced change
in host response kinetics, not an on-or-off switch. LPS plays
an enormous role in the pathogenesis of many gram-negative
infections, our data suggests a role for LPS Lipid A triggered
cell-cell communication as a factor in renal coagulation
following tubule infection.
Our data also introduces CD147 as the first host epithelial fac-
tor to be directly implicated in infection-mediated coagulation.
CD147, also known as EMMPRIN and Basigin (Grass and Toole
2015), is perhaps best recognized for its role in cancer, where it
acts to regulate the expression of VEGF and matrix metallopro-
teinase, contributing to malignancies (Grass and Toole 2015).
Targeting of CD147 has been suggested as a novel cancer treat-
ment strategy (Hao et al. 2010). In terms of bacterial infection,
CD147 has been implicated as an adhesion factor for Neisseria
meningitidis (Bernard et al. 2014) and Listeria monocytogenes (Till
et al. 2008). We show here that CD147 may play a role in infec-
tious cell signaling and the initiation of local coagulation during
renal infection. In support of our findings, CD147 has been
shown to be released from epithelial cells in vesicles and to alter
the angiogenic state of endothelial cells (Millimaggi et al. 2007).
We show that epithelial cells infected with the α-hemolysin ex-
pressing CFT073 strain secrete CD147. CD147 may be an effector
explaining the enhanced in vivo kinetics of infection-mediated
coagulation for the wild-type UPEC vs the α-hemolysin deficient
LT005 strain (Mansson et al. 2007). Further investigation of
the role of CD147 during renal infection in vivo is of huge
interest and the focus of ongoing work. Human CD147 however
exhibits only 65% homology with the rodent protein (Watan-
abe et al. 2010), making in vivo experimentation challenging
at this point.
While CD26, also known as dipeptidyl peptidase-4 (DPP4), did
not show a direct action on TF in our study, its high expression
during epithelial infection is also of interest. The DPP4 inhibitor
sitagliptin, an oral glucose-lowering agent, has been shown to
inhibit platelet aggregation (Gupta et al. 2012). Clinical trials with
sitagliptin also demonstrated an increased risk for urinary tract
infections (Amori, Lau and Pittas 2007). This suggests that CD26
may play a role in infection-mediated coagulation, just not via
TF activation as measured here.
Our work has revealed roles for bacterial LPS lipid A and host
CD147 in the modulation of infection-mediated coagulation ki-
netics. The picture that is emerging highlights the complexity,
cross talk and dynamics of renal infection. Understanding this
cross-talk will be important to evaluate the possible detrimen-
tal influence that seemingly unrelated treatments such as anti-
coagulation, cancer treatment (anti-CD147) and diabetes treat-
ment (anti-CD26) may have on infection progression in UTI. A
single molecular mechanism cannot control the multifaceted
tissue response to bacterial infection; evolution has ensured that
multiple pathways are involved, ensuring that fail-safes are in
place to prevent bacterial spread and life-threatening sepsis.
Learning to harness and enhance this host response is an at-
tractive possibility in the search for new treatments in the post-
antibiotic era.
SUPPLEMENTARY DATA
Supplementary data are available at FEMSPD online.
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